CYCLERION THERAPEUTICS, INC. Equity Securities Fv Ni Current And Noncurrent
CYCLERION THERAPEUTICS, INC. (CYCN) had Equity Securities Fv Ni Current And Noncurrent of $5.00 million as of 2023-03-31, per its S-4/A filed 2026-07-22.
Financial Statements › Balance Sheet › Assets
us-gaap:EquitySecuritiesFvNiCurrentAndNoncurrent · last filed 2026-07-22
- 2023-03-31: Equity Securities Fv Ni Current And Noncurrent $5.00M.
| Period end | Equity Securities Fv Ni Current And Noncurrent |
|---|---|
| 2023-03-31 | $5.00M S-4/A · filed 2026-07-22 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Citius Pharmaceuticals, Inc. (CTXR) | United States | $0.016B | -133.06 |
| Lantern Pharma Inc. (LTRN) | United States | $0.015B | -2.87 |
| Anebulo Pharmaceuticals, Inc. (ANEB) | United States | $0.015B | |
| ACTUATE THERAPEUTICS, INC. (ACTU) | United States | $0.015B | |
| Pasithea Therapeutics Corp. (KTTA) | United States | $0.017B | -0.81 |
| Tvardi Therapeutics, Inc. (TVRD) | United States | $0.014B | |
| Vyome Holdings, Inc (HIND) | United States | $0.014B | -1.38 |
| Allarity Therapeutics, Inc. (ALLR) | United States | $0.017B | -1.66 |
| PALATIN TECHNOLOGIES INC (PTN) | United States | $0.017B | -5.36 |
| Lipocine Inc. (LPCN) | United States | $0.017B | -1.79 |